老年糖尿病控制不佳患者潜伏结核筛查与治疗的前瞻性多中心研究
本研究在2家医院纳入980例年龄>45岁且糖化血红蛋白≥9%的糖尿病控制不佳患者,经内分泌科转介进行QuantiFERON潜伏结核筛查,阳性者由呼吸科给予3HP或9H预防治疗。26.6%患者QFT阳性,200例接受预防治疗,3HP和9H完成率分别为84.1%和79.0%,多学科协作下完成率可接近或超过80%。
要点
- 糖尿病控制不佳老年患者LTBI患病率超25%,应重视筛查。
- 年龄、糖尿病病程、CKD≥3期及部分降糖药使用与QFT阳性相关。
- 多学科协作下3HP或9H预防治疗完成率可接近或超过80%。
核心结论
- 老年糖尿病控制不佳患者LTBI患病率超过25%,在多学科团队照护下预防治疗完成率无论方案均可接近或超过80%。
研究设计与样本
- 前瞻性多中心研究,由公共卫生、内分泌和呼吸科多学科团队协作,纳入2家医院980例年龄>45岁且糖化血红蛋白≥9%的糖尿病控制不佳患者。
主要发现
- 980例患者中261例(26.6%)QFT阳性,年龄64.2±9.7岁。
- 200例(76.6%)QFT阳性患者接受预防治疗,其中3HP方案138例、9H方案62例。
- 3HP和9H完成率分别为84.1%和79.0%(P = .494)。
- 3HP组9例(6.5%)发生全身药物反应,9H组0例(P = .059)。
- 3HP组78.3%、9H组45.2%发生至少1种药物不良反应(P < .001);治疗后QFT转阴率分别为32%和20%(P = .228)。
临床怎么用
- 对糖尿病控制不佳的老年患者应开展LTBI筛查,阳性者可考虑预防治疗。
- 3HP或9H方案在多学科协作下完成率均较高,可根据安全性选择。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Poor control of diabetes mellitus (DM) increases active tuberculosis (TB) risk. Understanding risk factors for latent TB infection (LTBI) in this population and intervention completion rates is crucial for policy making. METHODS: Under a collaborative multidisciplinary team consisting of public health professionals, endocrinologists, and pulmonologists, patients aged >45 years with poorly controlled DM (pDM), defined as having a glycated hemoglobin level of ≥9% within the preceding year, were enrolled by endocrinologists from 2 hospitals; these patients underwent LTBI screening by using QuantiFERON (QFT). Once-weekly isoniazid and rifapentine for 12 weeks (3HP) or daily isoniazid for 9 months (9H) was administered by pulmonologists. QFT-positivity predictors were evaluated using logistic regression. Completion rates and safety were also investigated. RESULTS: Among 980 patients with pDM (age: 64.2 ± 9.7 years), 261 (26.6%) were QFT-positive. Age, DM duration, chronic kidney disease stage ≥3, and dipeptidyl peptidase-4 inhibitor use, not using metformin, were associated with QFT-positivity. Preventive therapy (3HP: 138; 9H: 62) was administered in 200 (76.6%) QFT-positive patients. The completion rates of 3HP and 9H were 84.1% and 79.0%, respectively (P = .494). Nine (6.5%) and zero patients in the 3HP and 9H groups, respectively, developed systemic drug reactions (P = .059); 78.3% and 45.2% had ≥1 adverse drug reactions (P < .001); and post-treatment QFT conversion rates were 32% and 20%, respectively (P = .228). CONCLUSIONS: LTBI prevalence exceeds 25% in elderly patients with pDM. Under care from a collaborative multidisciplinary team, the completion rate of preventive therapy, regardless of regimen could approach, or even exceed 80% in this population.
引用
- Huang HL, Huang WC, Lin KD, et al. Completion Rate and Safety of Programmatic Screening and Treatment for Latent Tuberculosis Infection in Elderly Patients With Poorly Controlled Diabetic Mellitus: A Prospective Multicenter Study. Clin Infect Dis. 2021. PMID: 33677558. doi:10.1093/cid/ciab209
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。